These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 56154)

  • 21. Immunostaining of plasma cells in primary biliary cirrhosis.
    Daniels JA; Torbenson M; Anders RA; Boitnott JK
    Am J Clin Pathol; 2009 Feb; 131(2):243-9. PubMed ID: 19141384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?
    Zein CO; Angulo P; Lindor KD
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):89-95. PubMed ID: 15017500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired monocyte function in primary biliary cirrhosis.
    Olmos JM; García JD; Jiménez A; de Castro S
    Allergol Immunopathol (Madr); 1988; 16(5):353-8. PubMed ID: 3228054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
    Zhang FK; Jia JD; Wang BE
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary biliary cirrhosis and hepatitis C virus infection.
    Floreani A; Baragiotta A; Leone MG; Baldo V; Naccarato R
    Am J Gastroenterol; 2003 Dec; 98(12):2757-62. PubMed ID: 14687829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.
    Bernstein RM; Neuberger JM; Bunn CC; Callender ME; Hughes GR; Williams R
    Clin Exp Immunol; 1984 Mar; 55(3):553-60. PubMed ID: 6368058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis.
    Sotaniemi EA; Hynnynen T; Ahlqvist J; Ahokas JT; Puoskari U; Pelkonen I
    J Med; 1978; 9(2):117-28. PubMed ID: 276564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current understanding of primary biliary cirrhosis].
    Il'ichenko LIu; Golovanova EV; Tsaregorodtseva TM; Serova TI; Gudkova RB
    Ter Arkh; 2005; 77(2):50-4. PubMed ID: 15807453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
    Zimmermann K; Cueni B; Schmid M
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1749-52. PubMed ID: 929135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between appendectomy and primary biliary cirrhosis.
    Rigopoulou EI; Georgiadou SP; Barbanis S; Dalekos GN
    Scand J Gastroenterol; 2006 May; 41(5):573-6. PubMed ID: 16638700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The dynamics of the morphological liver changes in primary biliary cirrhosis (based on the data from repeat biopsies)].
    Loginov AS; Aruin LI; Shepeleva SD; Tkachev VD
    Ter Arkh; 1994; 66(12):6-11. PubMed ID: 7900049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid.
    Güldütuna S; Leuschner U; Imhof M; Zimmer G
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():49-54. PubMed ID: 1449017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
    Twaddell WS; Lefkowitch J; Berk PD
    Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis.
    Van de Water J; Gerson LB; Ferrell LD; Lake JR; Coppel RL; Batts KP; Wiesner RH; Gershwin ME
    Hepatology; 1996 Nov; 24(5):1079-84. PubMed ID: 8903379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis.
    Poupon R; Chazouilleres O; Corpechot C; Chrétien Y
    Hepatology; 2006 Jul; 44(1):85-90. PubMed ID: 16799997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary biliary cirrhosis].
    Brailski Kh; Damianov B
    Vutr Boles; 1983; 22(5):27-37. PubMed ID: 6324495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome.
    Geubel AP; Baggenstoss AH; Summerskill WH
    Gastroenterology; 1976 Sep; 71(3):444-9. PubMed ID: 950095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overlap syndromes.
    Beuers U; Rust C
    Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.